Summary
LIBRA PHARMA is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €1.2m and a net result of €137,007. Equity is growing by about 12% per year across the filed financial years. Its solvency ranks better than 34% of 6,676 sector peers (NACE 64, financial year 2025). The company has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
07-07
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
2025
31-07
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format
2024
17-10
Gazette deed
Appointment: Esmoreit De Neef (director)2 facts ▸
Gazette deed
Appointment: Esmoreit De Neef (director)
2 facts ▸
- General meeting, 01-07-2024
- Director appointment, Esmoreit De Neef (director (not named in the articles))
30-08
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format · 30 days late
2023
31-12
Financial
Equity above €1mequity €1.0m ▲5.5%
A profit in every financial year since 2018 builds equity to €1.0m.
31-08
NBB filing
Annual accounts filed
financial year 2022 · abbreviated format · 31 days late
25-08
Gazette deed
Reappointment: BYTEBIER Kaatje (director)Amendment of the articles · Capital conversion · Reserve release9 facts ▸
Gazette deed
Reappointment: BYTEBIER Kaatje (director)
Amendment of the articles · Capital conversion · Reserve release9 facts ▸
- General meeting, 18-08-2023
- Amendment of the articles (2 times)
- Capital conversion, EUR, “eigen vermogensrekening “niet-opgevraagde inbrengen”” (deed in Dutch)
- Reserve release, “statutair onbeschikbare eigen vermogensrekening geheel opheffen en middelen beschikbaar maken voor uitkering, alle eigen vermogensbestanddelen beschikbaar” (deed in Dutch)
- Legal-form conversion, “besloten vennootschap” (deed in Dutch)
- Capital
- Director reappointment, BYTEBIER Kaatje (director)
- Registered office clause, “2531 Boechout,Vremdesesteenweg 259” (deed in Dutch)
- Other provision, “verklaring enige aandeelhouder, enige aandeelhouder” (deed in Dutch)
2022
31-12
Financial
Highest result from 2018 to 2025net €144,233 ▲0.6%
Net result €144,233, the highest in the series.
29-09
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format · 60 days late
2021
31-08
NBB filing
Annual accounts filed
financial year 2020 · abbreviated format · 31 days late
2020
21-09
NBB filing
Annual accounts filed
financial year 2019 · abbreviated format · 52 days late
2019
01-07
NBB filing
Annual accounts filed
financial year 2018 · abbreviated format
2018
28-06
NBB filing
Annual accounts filed
financial year 2017 · abbreviated format
2017
13-07
NBB filing
Annual accounts filed
financial year 2016 · micro format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 14 annual accounts filed, the latest 10 are here; all 14 are under Financials.
2 of 4 deeds read
About the unread acts
Of the 4 Belgian Official Gazette deeds we know for this company, 2 have been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.